How to Change Your Mind: The New Science of Psychedelics
When Nothing Else Has Worked
You’ve been in therapy a while. Tried the medications, done the CBT worksheets, and something still won’t budge. More and more people in that spot are showing up to sessions asking about psychedelics. Not because they want to get high. Because they’ve read that psilocybin might do something for treatment-resistant depression that years of SSRIs couldn’t touch, or that MDMA-assisted therapy is producing real results for people with severe PTSD. And they want to know whether any of it holds up.
Michael Pollan’s How to Change Your Mind: What the New Science of Psychedelics Teaches Us About Consciousness, Dying, Addiction, Depression, and Transcendence (Penguin Press, 2018) is one of the better starting points for that question. Pollan isn’t a therapist or a neuroscientist. He’s a journalist, and he approaches psychedelics the same way he approached food systems in his earlier work: with genuine curiosity, solid research, and enough skepticism to keep things honest.
What the Research Actually Shows
The core of the book is Pollan’s reporting on the clinical trials happening at Johns Hopkins, NYU, and Imperial College London. Researchers there have been studying psilocybin (the active compound in magic mushrooms) in controlled therapeutic settings, and the results are striking. Cancer patients facing terminal diagnoses reported lasting reductions in anxiety and depression after a single guided session. People with treatment-resistant depression showed significant improvement. Smokers with decades-long habits quit at rates that made existing cessation programs look modest.
Pollan doesn’t oversell these findings, which is part of what makes the book trustworthy. He’s careful to note sample sizes, acknowledge limitations, and distinguish between promising preliminary results and established medical consensus. The research is real and it’s encouraging, but it’s still early. That honesty matters, because the psychedelic space has a long history of overblown promises.

The History Nobody Talks About
Before getting to the current science, Pollan spends real time on why this research disappeared for decades. Psychedelics were being studied seriously in the 1950s and 60s, producing genuinely interesting results for alcoholism, end-of-life anxiety, and depression. Then Timothy Leary happened. The counterculture happened. Nixon’s War on Drugs happened. And an entire field of promising psychiatric research got shut down overnight.
This history section is more than just background. It explains why your therapist might not know much about psychedelic-assisted therapy yet, and why the legal situation is such a mess. It also explains the particular caution that surrounds the current research revival. The scientists working on this now are acutely aware that hype could kill the field again, and they’re being deliberate about moving slowly.
Pollan Tries It Himself
The book takes a personal turn when Pollan decides to try psychedelics himself. He’s in his early 60s, has no clinical diagnosis, and is by his own description a fairly conventional, somewhat anxious person. He works through several psychedelics over the course of the book — LSD, psilocybin across multiple sessions, and 5-MeO-DMT (the “toad” experience, a distinct compound from ayahuasca) — each in a different setting with a different guide.
His trip reports are some of the most grounded, well-written accounts you’ll find. He doesn’t romanticize the experiences or pretend they were all pleasant. Some were terrifying. Some were profoundly moving. What comes through most clearly is his description of ego dissolution: the temporary loss of the sense of a separate self. He writes about it not as mystical hand-waving but as a specific neurological event with real psychological consequences.
For someone curious about what a psychedelic experience actually feels like, stripped of both the counterculture mythology and the clinical jargon, this is genuinely useful reporting.
What This Means for Therapy
Here’s where the book connects to what actually happens in a therapy room:
- Treatment-resistant depression: The Johns Hopkins research on psilocybin for depression is some of the most compelling evidence in the book. For clients who’ve been through multiple medications and therapy modalities without breaking through, knowing that this research exists can be genuinely meaningful. Not as a replacement for therapy, but as context for where the field is heading.
- End-of-life anxiety: Pollan’s reporting on terminal cancer patients is hard to read and hard to dismiss. The reductions in existential dread that participants reported weren’t temporary mood boosts. They were lasting shifts in how people related to their own mortality. That has real implications for grief work and end-of-life care.
- Addiction: The smoking cessation studies and the earlier research on alcoholism suggest that psychedelics might help people break deeply entrenched patterns in ways that traditional approaches sometimes can’t. Pollan frames this through the lens of neuroplasticity: these substances seem to temporarily disrupt the default mode network, the brain’s autopilot, creating a window where old patterns become less fixed.
- Psychedelic integration: This is the part that connects most directly to therapy. A psychedelic experience by itself doesn’t do the therapeutic work. The integration afterward does. Making sense of what came up, connecting it to your life, figuring out what to do with the insights. That’s where a therapist who understands this terrain becomes essential.

Where the Book Has Limits
Pollan is a white, affluent, well-connected journalist, and his access shapes the story he tells. The underground guides he works with are largely in a particular demographic bracket. The clinical trials he reports on have their own diversity problems. Indigenous communities who’ve used these medicines for centuries get mentioned but don’t get centered. If you’re coming from a tradition where plant medicines have always been part of healing, this book may feel like it’s rediscovering something your culture already knew.
The science has also moved since 2018. MDMA-assisted therapy for PTSD has gone through Phase 3 trials. Psilocybin therapy is further along in several countries. Oregon has legalized psilocybin services. Some of what Pollan describes as future possibility is now present reality. The book remains a solid foundation, but you’ll want to supplement it with more recent reporting.
And Pollan’s personal experiences, while honest, are still one person’s account. Psychedelic experiences vary enormously based on set, setting, dosage, and individual neurology. His trips shouldn’t be taken as representative of what anyone else would experience.
About the Author
Michael Pollan is a journalist and professor who has written several books about the intersection of nature, culture, and human behavior. Two of them, The Omnivore’s Dilemma and In Defense of Food, reshaped how the country argues about food. He teaches writing at Harvard, and he’s been a contributing writer for The New York Times Magazine for decades.
How to Change Your Mind was a departure from food writing, but the method didn’t change. Go to where the science is happening. Talk to the people doing it. Figure out what’s actually going on under the headlines, then write it up for a general reader without dumbing it down. The book landed on the New York Times bestseller list, and Pollan has become one of the more visible public voices on psychedelic therapy since.
He followed this book with This Is Your Mind on Plants (2021), which explores caffeine, opium, and mescaline through a similar lens of personal experimentation and cultural history.
How to Change Your Mind doesn’t promise that psychedelics will fix everything. What it does well is lay out the actual evidence, give you enough history to understand why this field went dark for so long, and describe the experience itself without either glorifying it or reducing it to brain chemistry. If you’re curious about where psychedelic therapy is headed, or if you’re already thinking about integration work, this is a solid place to start. If that kind of exploration is something you want support around, our team includes therapists who work with psychedelic integration.
If you’re interested in how the body holds onto experiences the conscious mind can’t always access, The Body Keeps the Score covers complementary ground from a trauma perspective. And for understanding the internal-systems model that pairs well with psychedelic work, No Bad Parts is worth a look.

- Michael Pollan